These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19069159)

  • 1. [Current knowledge on the genetic factors involved in moyamoya disease].
    Hashikata H; Liu W; Mineharu Y; Inoue K; Takenaka K; Ikeda H; Houkin K; Kuroda S; Kikuchi K; Kimura M; Taki T; Sonobe M; Ban S; Nogaki H; Handa A; Kikuta K; Takagi Y; Nozaki K; Hashimoto N; Koizumi A
    Brain Nerve; 2008 Nov; 60(11):1261-9. PubMed ID: 19069159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease.
    Takagi Y; Kikuta K; Sadamasa N; Nozaki K; Hashimoto N
    Neurosurgery; 2006 Oct; 59(4):894-900; discussion 900-1. PubMed ID: 17038954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Moyamoya disease.
    Roder C; Nayak NR; Khan N; Tatagiba M; Inoue I; Krischek B
    J Hum Genet; 2010 Nov; 55(11):711-6. PubMed ID: 20739943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients.
    Roder C; Peters V; Kasuya H; Nishizawa T; Takehara Y; Berg D; Schulte C; Khan N; Tatagiba M; Krischek B
    Acta Neurochir (Wien); 2010 Dec; 152(12):2153-60. PubMed ID: 20571834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant moyamoya disease maps to chromosome 17q25.3.
    Mineharu Y; Liu W; Inoue K; Matsuura N; Inoue S; Takenaka K; Ikeda H; Houkin K; Takagi Y; Kikuta K; Nozaki K; Hashimoto N; Koizumi A
    Neurology; 2008 Jun; 70(24 Pt 2):2357-63. PubMed ID: 18463369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Suyama K; Nagata I
    Clin Neurol Neurosurg; 2013 Jul; 115(7):930-3. PubMed ID: 23041378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan.
    Lee MJ; Chen YF; Fan PC; Wang KC; Wang K; Wang J; Kuo MF
    J Neurol Sci; 2015; 353(1-2):161-5. PubMed ID: 25956231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral infarction associated with moyamoya disease: histogram-based quantitative analysis of diffusion tensor imaging -- a preliminary study.
    Mori N; Miki Y; Fushimi Y; Kikuta K; Urayama S; Okada T; Fukuyama H; Hashimoto N; Togashi K
    Magn Reson Imaging; 2008 Jul; 26(6):835-40. PubMed ID: 18467061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Susceptibility Pathogenesis of Moyamoya Disease.
    Hu J; Luo J; Chen Q
    World Neurosurg; 2017 May; 101():731-741. PubMed ID: 28153617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.
    Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T
    Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke in a postpartum patient: understanding the epidemiology, pathogenesis, and outcome of Moyamoya disease.
    Ishimori ML; Cohen SN; Hallegua DS; Moser FG; Weisman MH
    Semin Arthritis Rheum; 2006 Feb; 35(4):250-9. PubMed ID: 16461070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Risk for Moyamoya Disease Among First-Degree Relatives, Based on a Population-Based Aggregation Study in Korea.
    Ahn HS; Kazmi SZ; Kang T; Kim DS; Ryu T; Oh JS; Hann HJ; Kim HJ
    Stroke; 2020 Sep; 51(9):2752-2760. PubMed ID: 32811391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and genetic factors in moyamoya disease.
    Achrol AS; Guzman R; Lee M; Steinberg GK
    Neurosurg Focus; 2009 Apr; 26(4):E4. PubMed ID: 19335130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya disease: a review of histopathology, biochemistry, and genetics.
    Weinberg DG; Arnaout OM; Rahme RJ; Aoun SG; Batjer HH; Bendok BR
    Neurosurg Focus; 2011 Jun; 30(6):E20. PubMed ID: 21631222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review.
    Rallo MS; Akel O; Gurram A; Sun H
    Neurosurg Focus; 2021 Sep; 51(3):E5. PubMed ID: 34469865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
    Park MG; Shin JH; Lee SW; Park HR; Park KP
    J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inheritance of moyamoya disease in a Caucasian family.
    Kraemer M; Heinemann FM; Horn PA; Venker C; Berlit P; Krischek B; Khan N
    Eur J Neurol; 2012 Mar; 19(3):438-42. PubMed ID: 21974719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of TGFB1 in European and Japanese Moyamoya disease patients.
    Liu C; Roder C; Schulte C; Kasuya H; Akagawa H; Nishizawa T; Yoneyama T; Okada Y; Khan N; Tatagiba M; Berg D; Krischek B
    Eur J Med Genet; 2012 Oct; 55(10):531-4. PubMed ID: 22659181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Moyamoya disease].
    Tokunaga K; Date I
    Brain Nerve; 2008 Jan; 60(1):37-42. PubMed ID: 18232331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.